Rheumatology
News, opinions and meeting coverage in rheumatology.
— Australian researchers perform "target trial emulation" to compare popular drugs
Latest in Rheumatology
Australian trial finds no difference in pain scores over 6 weeks
One specific gut microbe may be a major factor
Trial data show rates higher, though still low, with drug versus placebo
Randomized study finds no disparities in biologics prescribing, but questions linger
Trial data show rates higher, though still low, with drug versus placebo
Randomized study finds no disparities in biologics prescribing, but questions linger
Rheumatology Case Studies
Numerous diagnostic procedures revealed tophaceous gout affecting the middle ear
Joint stiffness is just one symptom of this rare debilitating inflammatory disease
Prompt diagnosis of this rare progressive autoimmune disease may help preserve hearing, eyesight
More in Rheumatology
New "points to consider" document lists early warning signs
Novel agent adds additional action in hopes of improving efficacy
Phase III results back potential competitor for pegloticase-methotrexate treatment
Of three major prognostic tools, none hit the mark
New study finds marked risk reduction tied to drugs' urate-lowering effect
Stunning improvement for two patients with rare form of autoimmune myositis
Study finds genetic basis long sought in disabling pansclerotic morphea, leading to effective tx
Familiar biologic halts progression in high-risk patients with just a few painful joints
In separate studies, one old standby and one newer biologic appeared helpful
Disease characteristics, risk factors for complications differ between young and old
Publication comes after another study's failure to demonstrate benefit
Health news and commentary from around the Web gathered by MedPage Today staff
A 52-year-old woman presented to the doctor with left anterior ankle pain and foot swelling, decreased range of motion, and gait disturbance that had developed steadily over the past 4-6 weeks. Can you diagnose the patient?
